IPN Sponsors

  The ABCD Insulin Pump Network is grateful to the following organisations for supporting the operational activity of the Insulin Pump Network

ABCD Corporate Pump and Device Supporters

Gold sponsors

Abbott Diabetes Care

 At Abbott, we’re committed to helping you live your best possible life through the power of health. For more than 125 years, we’ve brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 74,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

Abbott

Ascensia Diabetes Care

Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.

Home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.

Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Ascensia Diabetes Care has around 1,700 employees and operations in 33 countries.

For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com. CONTOUR® is a registered trademark of Ascensia Diabetes Care Holdings AG.

Dexcom Inc

Dexcom, Inc., headquartered in San Diego, CA, soon to be direct in the UK, is dedicated to helping people better manage their diabetes by providing exceptional continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. Our latest-generation CGM, the Dexcom G5® Mobile CGM System, is the first FDA-approved, fully mobile System for both adults and children 2 years and older. Patients can view not only their real-time glucose data via their hand held Receiver or compatible smartphone* but also share it with loved ones.  Our CGM features a 7-day-wear sensor as well as customizable alerts and a built-in low alarm to warn patients of the speed and direction of highs and lows. For more information, visit www.dexcom.com/en-GB

*To view a listing of compatible smartphones, visit www.Dexcom.com/compatibility

Roche Diabetes Care
Roche Diabetes Care is a global leader for innovative diabetes management solutions. For more than 40 years, the company has been dedicated to empower people with diabetes and healthcare professionals to optimally manage the condition. Today, the Accu-Chek portfolio encompasses smart solutions for bG monitoring, bolus advice and discreet remote control insulin pump technology with the Accu-Chek Combo and Accu-Chek Insight systems. Accu-Chek solutions contribute to optimal and personalised diabetes management, leading to improved outcomes and contributing to therapy success for people with diabetes.

Roche

 

Silver sponsors                              

Cellnono Logo
 

Cellnovo 

Combining the latest in insulin pump technology with m-Health Cellnovo is proud to have developed our mobile diabetes management system in the UK and launched in 2014 at selected UK centres. Cellnovo products are manufactured in South Wales and having secured additional funding through an IPO in 2015, we are now able to offer the system to a growing number of centres in the UK and Europe. The Cellnovo system incorporates a miniaturised insulin pump with a discrete, tubeless, small and wearable device. It also allows patients to capture blood glucose readings, carbohydrate intake, bolus calculations, and activity levels. A first in insulin pump therapy, the system communicates data from the users pump, automatically to a secure online platform. This allows both patients and clinicians immediate access to real time diabetes management data and removes downloading requirements. For more information visit www.cellnovo.com


Medtronic Ltd

Medtronic was founded in 1949.  Since then we have grown into a multinational company that uses technology to transform the way debilitating, chronic diseases are treated. Effective diabetes management and monitoring tools like the MinIMed® 640G with SmartGuard® and CareLink® Therapy Management Software can help people living with diabetes lead a full and active life.

To find out more about Medtronic’s diabetes products, services and support for healthcare professional, patients and carers please visit: www.medtronic-diabetes.co.uk . Medtronic UK offices are based in Watford, Herts

Bronze Sponsors

 
 

 

The sponsoring companies are not responsible for the content of this website.